Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) 
Introduction
During the last decade, the potential of human induced pluripotent stem cell-derived cardiomyocytes (hiPSCCMs) has been remarked for many different applications, ranging from regenerative medicine, to personalized medicine, to drug tests. The potential of hiPSC-CMs for drug testing was acknowledged also in the new Comprehensive In vitro Proarrhythmia Assay (CiPA) paradigm for drug safety testing. In fact, CiPA aims to combine in vitro (hiPSC-CMs) and in silico (computational models of cardiac cells) technologies to overcome the limits of the current safety pharmacology paradigm (i.e. the focus on hERG channel block in vitro and the QT prolongation in vivo) [1] . However, the use of hiPSC-CMs poses new challenges, e.g. differences compared to adult cardiac [2] cells and the extreme variability of the experimental data. hiPSC-CMs variability represent a big challenge, as shown by plethora of in vitro datasets published during the last five years. Recently, a hiPSC-CM in silico model was proposed (Paci2015) [2, 3] , but due to its intrinsic development, it cannot capture the hiPSC-CM variability since i) it reproduces the average behaviour of an in vitro hiPSCCMs population and ii) such population refers to a single dataset [4] . The aim of this paper is tackling the hiPSCCMs variability issue in silico, using the new "population of models" (POM) paradigm [5] . In detail, we aim to overcome the limits of the Paci2015 model and capture the variability observed in literature, with particular focus on the effects of a strong block of IKr, which has been reported to induce Early After Depolarizations (EADs), in some cells but not in others. E.g. in [4] only three out of five cells showed EADs, but the Paci2015 model did not simulate such phenomenon.
Methods
The POM paradigm consists in two separate steps: i) the generation of a first population of in silico models, by sampling the parameters of interest and ii) calibrating the first population using the available experimental data, thus discarding those model which are not in agreement with the experimental evidences. We followed these two steps to obtain an in silico hiPSC-CM population, which is then used to test a strong blockade of IKr.
Parameter sampling and model generation
The first population was generated using the Paci2015 model and sampling the maximum conductances of 11 currents: fast and late Na [5] , which allows an even sampling of the parameter spaces. LHS produced 10000 sets of 11 coefficients each, ranging in [0. 5, 2] which were used to modulate the aforementioned 11 currents, thus generating a first population of 10000 hiPSC-CM models. Simulations were run for 800 s to drive the models to the steady state.
Calibration of the first population
To calibrate the hiPSC-CM population, we used six datasets of spontaneous action potentials (APs) available in literature, namely Ma2011 [4] , Moretti2010 [6] , Ma2013 [7] , Fatima2013 [8] , Lahti2012 [9] and Kujala2012 [10] , where biomarkers such as AP duration (APD), maximum diastolic potential (MDP) and rate of spontaneous beating (RATE) where reported in terms of mean (μ) and standard error (SEM). For each biomarker we consider the biomarker space as μ ± 2 standard ), hypothesizing a uniform distribution. Due to the variability of the datasets, we joined them together in a conservative way, i.e. considering as lower and upper bounds for each biomarker the smallest and the biggest among the six datasets, respectively (Table 1) . Not meaningful bounds (e.g. negative RATE or APD) were set to 0. In order for a model to be included into the final population, every biomarker must be included in the aforementioned biomarker spaces. Since we focused on spontaneously beating in silico models, we introduced two more conditions than in [5] to accept a model into the final population: i) the model must generate spontaneous APs and ii) the intracellular ionic concentrations must be
IKr block
To assess the behaviour of the in silico hiPSC-CM population we tested an extreme IKr block (90%) for 800 s starting from the models' steady states.
Results

The hiPSC-CM population
Out of the 10000 hiPSC-CM models generated by sampling, only 1355 were accepted in the final population after calibration. A global view of the hiPSC-CM population is reported in Figure 1 , while the biomarker variability is reported in Table 1 . In Figure 2 we show 
IKr block
The 90% block of IKr on the 1355 hiPSC-CM models, generated three different profiles: 562 models with normal repolarization (REPO), 336 models showing EADs (EAD) and 457 which failed to repolarize (REPOFAIL). Three illustrative APs are reported in Figure 3 . For the REPO models, the mean APD90 prolongation is (μ±SEM) 723±12 ms. To assess the 
Discussion and conclusions
In this paper, we presented a new application of the POM paradigm: generating a population of hiPSC-CM in silico models. Our study shows that in a context of extreme variability of the experimental data ( Figure 2 ) a single in silico model, although informative, results partially inadequate to capture the complexity of the electrophysiological behavior of a cellular type. In particular for safety pharmacology purposes, a population of hiPSC-CM models provides a more comprehensive picture on the responses to hiPSC-CMs to drugs. In spite of the fact that a prototypical block was here simulated, the responses of the population models were quite various: from the expected prolongation of APD, to the occurrence of EADs and repolarization failures. We ascribe such different behaviors to a different equilibrium of the ionic currents (in this case their maximum conductances), that in REPO models allow normal APs, but in the EAD and REPOFAIL models, are not able to 
